Budapest, Hungary

Csongor Hegedus

This inventor holds 1 USPTO granted patent. Top assignee: Medicor Muvek. Active years: 1979.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Csongor Hegedus: Innovator in Glaucoma Investigation

Introduction

Csongor Hegedus is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of eye therapeutics, particularly in the investigation of glaucoma. His innovative approach combines technology and medical science to enhance the examination of the human eye.

Latest Patents

Hegedus holds a patent for a "Method and apparatus for investigation of glaucoma in eye therapeutics." This invention features an apparatus designed to examine the human eye for the onset of glaucoma. The apparatus utilizes a virtual capacitor formed by the eye and a gas nozzle. The examination process involves a gas jet directed at the eye, with measurements taken to assess the deformation of the eye's surface caused by the dynamic pressure of the gas jet. This method allows for sampling at moments determined by the systolic rhythm of the person being examined, providing valuable insights into the eye's dynamic performance.

Career Highlights

Csongor Hegedus is associated with Medicor Muvek, where he applies his expertise in developing innovative medical devices. His work has been instrumental in advancing techniques for glaucoma detection and management.

Collaborations

Hegedus has collaborated with notable colleagues, including Jozsef Czine and Jozsef Bencze. Their combined efforts contribute to the ongoing development of effective medical technologies.

Conclusion

Csongor Hegedus stands out as an inventor dedicated to improving eye health through innovative solutions. His patent for investigating glaucoma exemplifies his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…